Skip to content

Advertisement

  • Research article
  • Open Access

Plasmid pPCP1-derived sRNA HmsA promotes biofilm formation of Yersinia pestis

BMC MicrobiologyBMC series – open, inclusive and trusted201616:176

https://doi.org/10.1186/s12866-016-0793-5

©  The Author(s). 2016

  • Received: 24 March 2016
  • Accepted: 29 July 2016
  • Published:

Abstract

Background

The ability of Yersinia pestis to form a biofilm is an important characteristic in flea transmission of this pathogen. Y. pestis laterally acquired two plasmids (pPCP1and pMT1) and the ability to form biofilms when it evolved from Yersinia pseudotuberculosis. Small regulatory RNAs (sRNAs) are thought to play a crucial role in the processes of biofilm formation and pathogenesis.

Results

A pPCP1-derived sRNA HmsA (also known as sR084) was found to contribute to the enhanced biofilm formation phenotype of Y. pestis. The concentration of c-di-GMP was significantly reduced upon deletion of the hmsA gene in Y. pestis. The abundance of mRNA transcripts determining exopolysaccharide production, crucial for biofilm formation, was measured by primer extension, RT-PCR and lacZ transcriptional fusion assays in the wild-type and hmsA mutant strains. HmsA positively regulated biofilm synthesis-associated genes (hmsHFRS, hmsT and hmsCDE), but had no regulatory effect on the biofilm degradation-associated gene hmsP. Interestingly, the recently identified biofilm activator sRNA, HmsB, was rapidly degraded in the hmsA deletion mutant. Two genes (rovM and rovA) functioning as biofilm regulators were also found to be regulated by HmsA, whose regulatory effects were consistent with the HmsA-mediated biofilm phenotype.

Conclusion

HmsA potentially functions as an activator of biofilm formation in Y. pestis, implying that sRNAs encoded on the laterally acquired plasmids might be involved in the chromosome-based regulatory networks implicated in Y. pestis-specific physiological processes.

Keywords

  • Yersinia Pestis
  • Crystal Violet Staining
  • Primer Extension Assay
  • Ferric Uptake Regulator
  • sRNA Candidate

Background

The genus Yersinia is composed of 11 species, including three human pathogenic species: Yersinia pestis, Yersinia pseudotuberculosis and Yersinia enterocolitica. Y. pestis is thought to have evolved from Y. pseudotuberculosis 5021–7022 years ago [1]. Despite >90 % genome identity between Y. pestis and Y. pseudotuberculosis, the disease caused by these two species differs dramatically. Y. pseudotuberculosis is a self-limiting gastroenteric pathogen that does not usually form biofilms [2, 3]. By contrast, Y. pestis is a deadly pathogen responsible for three human plague pandemics. It is transmitted to mammals and/or humans by infected flea bites or by direct contact with infected animals [4]. Y. pestis must survive and adapt to the complex microenvironments of multiple hosts during its infectious process [4, 5]. During its evolution from Y. pseudotuberculosis, Y. pestis acquired two unique plasmids, pPCP1 and pMT1, which are crucial for the processes of pathogenesis and flea transmission [6–8]. Plasmid pPCP1 is a 9.5 kb plasmid that encodes the plasminogen activator Pla, a surface protease that is essential for mediating primary pneumonic plague [7, 9].

The formation of biofilm within the flea digestive tract is important for natural transmission of Y. pestis because complete blockage of the proventriculus promotes frequent biting by fleas and thus increases the opportunities for transmission [4, 10]. A dense bacterial aggregate embedded in a self-produced exopolysaccharide (EPS) matrix facilitates the adaptation to complex microenvironments [3, 10, 11]. The hmsHFRS locus encodes the structural proteins required for the synthesis and transport of EPS, a major component of the Y. pestis biofilm [12, 13]. EPS expression is controlled at the post-transcriptional level by the intracellular concentration of the c-di-GMP second messenger [14], which is synthesized by diguanylate cyclases HmsD/HmsT and degraded by the phosphodiesterase HmsP in Y. pestis [15–17]. Several transcriptional regulators have been discovered that are involved in biofilm formation in Y. pestis. For example, Fur, a regulator of iron metabolism, can repress biofilm formation by negatively regulating the hmsT gene [18]. RcsA, a negative regulator of biofilms, is reported to be functionally defective in Y. pestis [19]. RovM, which is directly induced under specific microenvironments and represses the expression of the rovA gene, also regulates biofilm formation [20]. We recently reported the role of RovA in biofilm formation of Y. pestis [21]. The PhoPQ two-component system, a LysR-type transcriptional regulator YfbA and the carbon storage regulator CsrA have recently been shown to contribute to biofilm formation of Y. pestis [22–24].

Y. pestis has to adapt to diverse environmental conditions during its complex life cycle by modulating the expression of metabolic, cell surface and virulence factors. In bacteria there are different levels at which gene expression can be regulated. Small regulatory RNAs (sRNAs) play important regulatory roles at the post-transcriptional level in bacterial physiology and pathogenesis, including biofilm formation [25]. They are reported to exert their regulatory functions by interacting with specific mRNAs or proteins and thus influence translation and mRNA stability upon sensing environmental cues [26, 27]. The identification of more than 100 sRNAs, identified by RNomics and deep sequencing, facilitates the study of post-transcriptional mechanisms of gene regulation in Y. pestis [28–32]. Post-transcriptional regulation and the underlying role of certain novel sRNAs in virulence and host adaptation have begun to be addressed in the genus Yersinia in recent years [32–34].

HmsB, a chromosome-encoded sRNA (also known as sR035), was identified by our previous study [28] and subsequently shown to promote biofilm formation by increasing EPS production in Y. pestis [35]. The plasmid pPCP1-deriving sRNA HmsA (also known as sR084) was initially found to be highly abundant in Y. pestis grown in vitro and positively regulated by the CRP protein, a global regulator of catabolite repression [28]. Here we observed an altered biofilm phenotype in the hmsA mutant of Y. pestis. Based on results measuring the abundance of mRNA transcripts determining EPS production, HmsA was found to potentially function as an activator of biofilm formation in Y. pestis by modulating the intracellular level of c-di-GMP molecules. Interestingly, the recently identified biofilm-associated sRNA, HmsB, was significantly downregulated in the hmsA deletion mutant. Furthermore, transcription of the biofilm regulators, RovA and RovM, also seemed to be affected by HmsA, which might partially account for the biofilm phenotype.

Methods

Bacterial strains

Bacterial strains, plasmids and primers used in this study are listed in Table 1. Y. pestis wild-type (WT) strain 201 belongs to biovar Microtus, which is avirulent in humans but highly virulent in mice [36]. Except for the pPCP1-cured strain, all mutant strains used here were constructed by replacing the entire gene with the kanamycin resistance cassette using the λ-Red homologous recombination system [37]. The pPCP1-cured strain derived from strain 201 was constructed based on plasmid incompatibility by Bin et al. in our laboratory [38]. To obtain the HmsA overexpression strain, the arabinose-inducible transcriptional plasmid pBAD-TF was modified using the QuikChange® Lightning Site-Directed Mutagenesis Kit (Stratagene) as previously described [39]. The HmsA overexpression plasmid (pBAD-HmsA) was constructed by ligating the PCR-generated DNA fragment spanning the full-length hmsA gene (65 nt) and the 27-nt downstream region of hmsA into the modified vector. The HmsA overexpression strain ∆hmsA::HmsA was generated by introducing plasmid pBAD-HmsA into the hmsA deletion mutant (∆hmsA).
Table 1

Bacterial strains, plasmids and oligonucleotides used in this study

Strains

Name

Description

Sources

WT

Y. pestis wild-type strain 201

[36]

WT::pBAD

Y. pestis WT strain carrying plasmid pBAD-TF

[39]

∆pPCP1

Y. pestis WT strain lacking plasmid pPCP1

[38]

∆hmsA

hmsA deletion mutant derived from Y. pestis WT strain 201

[28]

∆hmsA::pBAD

∆hmsA strain carrying plasmid pBAD-TF

This study

∆hmsA::HmsA

∆hmsA strain carrying plasmid pBAD-HmsA

This study

∆hmsS

hmsS deletion mutant derived from Y. pestis WT strain

[18]

∆fur

fur deletion mutant derived from Y. pestis WT strain

[18]

∆hmsB

hmsB deletion mutant derived from Y. pestis WT strain

[35]

Plasmids

pRW50

A low-copy lacZ fusion vector

[42]

pBAD-TF

Transcriptional fusion vector modified from pBAD/HisA

[39]

pBAD-HmsA

HmsA overexpressing plasmid by inserting a DNA fragment amplified by primer HmsA-pBAD-F/R into pBAD-TF

This study

Oligonucleotides

Name

Sequence (5′-3′)

HmsA-pBAD-F/R

CACGAATTCGCAAAAGTCAGGACTAGACATATTAAC/TTGAAGCTTACCACATAAAAAAGGCCCTCACAGG

HmsA-NB-F/R

CACGAATTCGCAAAAGTCAGGAC/AATTGTAATACGACTCACTATAGGGCGTTGAAGCTTACCACATAAAAAAGGC

HmsB-NB-F/R

TGTAATAATAGTCATATCATCGTAAATTTGAATTGTAATACGACTCACTATAGGGCGTGCTTCAGTGGCTCATGTC

HmsA-PE-R

TCTGTGAGGGCGTATGATAAGG

Biofilm formation assays

Three methods were used to evaluate biofilm formation by Y. pestis, as described previously [18]. For the rugose colony morphology assay, 5 μL of bacterial glycerol stocks were spotted onto LB plates, which were dried for 2 d at 37 °C and cooled for at least 2 h at room temperature, these plates were incubated at 26 °C for 1 week. The surface morphology of each bacterial colony was photographed.

A crystal violet staining assay was used to detect biofilm formation in vitro. One hundred microliters of bacterial glycerol stock were added to 18 mL of LB medium for cultivation to stationary phase at 26 °C. The bacterial cultures were diluted 1:20 into 18 mL of LB medium for cultivation to an optical density (OD620) of about 1.0 and stored at 4 °C for 8 h. The bacterial cultures were diluted 1:20 and 1 mL of the diluted cultures was transferred into the 24-well tissue culture plates; these plates were incubated with shaking at 230 rpm for 24 h at 26 °C. The OD620 values of the cultures containing planktonic cells were determined and used for normalization. The pellicle was gently washed three times with H2O, and incubated at 80 °C for 15 min. The biofilms were stained with 2 mL of 0.1 % crystal violet for 15 min. The wells were washed three times with 2 mL of H2O, the biofilms were dissolved with 2 mL of dimethylsulfoxide for 1 h. Crystal violet staining was determined by the OD570 values and the relative amount of biofilm formation was indicated by the OD570/OD620 values. Three biological replicates and two technical replicates were performed for each strain.

For Caenorhabditis elegans killing assays, bacterial biofilm formation in vivo was determined by the percentage of fourth-stage larvae and adults (L4/adult) of C. elegans after incubation of nematode eggs on Y. pestis lawns. The nematode eggs were collected from lysates of adult C. elegans grown on Escherichia coli OP50 lawns on NGM agar plates. About 200 to 300 nematode eggs were placed on each bacterial lawn, followed by incubation at 20 °C for 72 h, the number of nematodes, fourth-stage larvae and adults of C. elegans were counted. Three biological replicates were performed for each strain.

Measurement of the intracellular c-di-GMP levels

The intracellular c-di-GMP levels were determined by a chromatography-coupled tandem mass spectrometry (HPLC-MS/MS) method. One hundred microliters of bacterial glycerol stocks were added to 18 mL of LB medium for cultivation to stationary phase at 26 °C. The bacterial cultures were diluted 1:20 into 18 mL of LB medium for cultivation to an OD620 of about 1.0, and were then stored at 4 °C for 8 h. The bacterial cultures were diluted 1:20 into 18 mL LB medium for cultivation to middle exponential phase (OD620 ≈ 1.0) at 26 °C. Bacterial cultures were harvested for the extraction of c-di-GMP. The samples were loaded onto an API 4000-QTRAP mass spectrometer equipped with an electrospray ionization source (Applied Biosystems). One microliter of bacterial culture was harvested and the protein concentration was determined using a Micro BCA Protein Assay Kit (Thermo Scientific). The c-di-GMP levels were expressed as pmol/mg of bacterial protein.

RNA extraction and northern blotting

Y. pestis strains were grown in LB medium at 26 °C to an OD620 of about 1.0 and stored at 4 °C for 8 h. The bacterial cultures were diluted 1:20 into 18 mL LB medium for cultivation to middle exponential phase (OD620 ≈ 1.0) at 26 °C. Before harvesting, bacterial cultures were mixed with double-volume RNAprotect Regent (Qiagen) to minimize RNA degradation. Total RNA was isolated using TRIzol Reagent (Invitrogen). The quantity and quality of RNA were determined by NANODROP spectrophotometry (Thermo Scientific). Northern blotting was carried out using a DIG Northern Starter Kit (Roche) following the manufacturer’s protocol as described by Beckmann et al. [40]. Total RNA samples (5–10 μg) were denatured at 95 °C for 3 min, separated on 6 % polyacrylamide-7 M urea gels, and RNA samples were transferred onto Hybond N+ membranes (GE Healthcare) by electroblotting. The membranes were UV-crosslinked and pre-hybridized for 1 h, and DIG-labeled RNA probes generated using the primers HmsA/HmsB-NB-F/R were added. The membranes were then hybridized overnight at 68 °C in DIG Easy Hyb buffer (Roche) according to the manufacturer’s protocols. Multiple exposures to X-ray film were taken to achieve the desired signal strength. RNA probes were synthesized by in vitro transcription using T7 RNA polymerase, then RNA was immunologically detected and scanned.

Primer extension assay

Primer extension assays were performed using a primer extension system-AMV reverse transcriptase kit (Promega) as previously reported by our group [41] with slight modifications. Total RNA (10 μg) was reverse-transcribed using the 32P-labelled primer HmsA-PE-R. The cDNA products were subjected to electrophoresis in a 6 % polyacrylamide-8 M urea gel. The gel was then analyzed by autoradiography (Kodak film). To serve as sequence ladders, sequencing reactions were also performed with the same primers used for primer extension, using the AccuPower & Top DNA Sequencing Kit (Bioneer).

β-galactosidase assay

Genes with a promoter-proximal DNA region were cloned into the low-copy-number transcriptional fusion vector pRW50 [42], which harbors a promoterless lacZ reporter gene. The recombinant plasmid or the empty pRW50 (negative control) was transformed into Y. pestis strains and the β-Galactosidase Enzyme Assay System (Promega) was used to measure β-galactosidase activity in three independent cellular extracts [18].

Quantitative RT-PCR (qRT-PCR)

The cDNA was synthesized from 5 μg of RNA using the ThermoScrip RT-PCR System (Invitrogen). Real-time PCR was performed in duplicate for each RNA sample using the TransStart™ Green qPCR SuperMix UDG (TransGen Biotech) with an appropriate cDNA dilution as a template. Three biological replicates were performed for each strain. Control reactions were carried out in parallel in the absence of the reverse transcriptase, 16S rRNA was used as an internal standard to normalize the expression levels of the tested sRNA candidates. Relative quantitative analysis was performed across different cDNA templates using the LightCycler 480 software (Bio-Rad).

Results

Enhanced role of HmsA in biofilm formation

HmsA, a pPCP1 plasmid-derived sRNA, was previously identified as an Hfq-dependent sRNA in Y. pestis by RNA-seq in our laboratory. To determine the function of HmsA, we constructed a hmsA deletion mutant ΔhmsA and an inducible HmsA-overexpressed strain ΔhmsA::HmsA. The pBAD promoter driving hmsA expression from pBAD-TF was induced by the addition of 0.1 % arabinose. We found that deletion of hmsA did not affect the growth rate of Y. pestis strain 201 in LB medium (Additional file 1: Figure S1). Colony morphology was much smoother in pPCP1-null Y. pestis than WT strain 201 (Fig. 1a), suggesting the role of plasmid pPCP1 in the biofilm phenotype. To further investigate the contribution of HmsA to the regulation of biofilm formation in Y. pestis, the rugose colony assay was initially performed. The ∆fur or ∆hmsS mutants were used as positive and negative controls, respectively, for the biofilm formation assays. The relatively smooth colonies of Y. pestis ΔhmsA were compared with those of the WT strain (Fig. 1a). Smooth colony morphology was exhibited by the HmsA overexpressed strain upon induction with arabinose, suggesting that HmsA positively regulates expression of biofilm-associated genes.
Fig. 1
Fig. 1

Biofilm formation capacity and c-di-GMP production mediated by HmsA. a Bacterial colony morphology. The WT::pBAD, ∆hmsA::pBAD and ∆hmsA::HmsA strains were incubated on LB agar with 0.1 % arabinose designated as “+Ara” (middle row). The ∆hmsS or ∆fur strains were used as negative or positive controls for this assay, respectively (bottom row). b Crystal violet staining. Biofilms were quantified by crystal violet staining in the WT, ∆hmsA and ∆hmsA::HmsA strains grown in LB medium with the addition of 0.1 % arabinose. The ∆hmsS strain was grown under the same conditions as the negative control. Data are presented as the average of three separate experiments and error bars represent the standard deviation. c C. elegans biofilms. The percentage of L4/adults after incubation of nematode eggs on a lawn of the indicated Y. pestis strains was used to evaluate the capacity for biofilm formation. d Intracellular c-di-GMP concentration

The role of HmsA as a regulator of biofilm formation was subsequently confirmed by crystal violet staining and nematode development assays. Quantitative determination by crystal violet staining revealed an approximately 50 % decrease in bacterial biofilm of the Y. pestis ΔhmsA mutant at the air-liquid interface compared with the WT strain and the ΔhmsA::HmsA strain (Fig. 1b). Incubation of nematode eggs on bacterial lawns of the WT and ΔhmsA::HmsA strain, revealed that only a small percentage (below 20 %) of eggs grew to L4/adult nematodes due to abundant attachment of biofilms to nematode heads. By contrast, bacterial lawns of the ∆hmsA and ∆hmsS mutant strains allowed the growth of about 40 % and 95 % of eggs into L4/adult nematodes, respectively (Fig. 1c). These results indicated that HmsA enhances biofilm formation in Y. pestis.

Impact of HmsA on the biosynthesis of c-di-GMP molecules

Biofilm formation in Y. pestis is regulated by the intracellular concentration of the second messenger c-di-GMP. As HmsA influences the extent of biofilm formation by Y. pestis, we hypothesized that deletion of hmsA would result in decreased c-di-GMP levels. To test the effect of HmsA on c-di-GMP synthesis in Y. pestis cells, the concentration of c-di-GMP was determined in the WT, ∆hmsA and ΔhmsA::HmsA strains by HPLC-MS/MS. The production of c-di-GMP was clearly reduced in the ∆hmsA mutant compared with the WT and ΔhmsA::HmsA mutant (Fig. 1d). The c-di-GMP levels were comparable between the WT and ΔhmsA::HmsA strain grown under the same conditions. However, absence of the hmsA gene resulted in a reduction in c-di-GMP levels by about 50 %. These data indicated that HmsA plays a role in modulation of c-di-GMP levels, and that c-di-GMP levels correlate with the amount of biofilm produced.

HmsA affects the transcriptional regulation of structural genes for EPS synthesis

Most sRNAs derived from intergenic regions act as trans-acting sRNAs repressing translation and destroying mRNA stability via base pairing with their target mRNAs. Translational repression of a target mRNA results in active or passive mRNA degradation. We used a primer extension assay and RT-PCR to determine the HmsA-mediated regulatory effects on biofilm-related genes at the transcriptional and post-transcriptional level in Y. pestis. A lacZ transcriptional fusion assay was also performed to explore the possibility that abundance changes occur at the transcriptional level.

The main component of Y. pestis biofilm, EPS, is encoded by the structural hmsHFRS operon. To investigate whether HmsA affects the mRNA level of hmsHFRS, the first gene hmsH was chosen for further analysis of transcriptional regulation in the WT and ΔhmsA mutant strain (Fig. 2). Relative to the WT strain, the absence of hmsA resulted in a decrease in hmsH transcript. However, the lacZ fusion assay indicated that hmsH is significantly downregulated upon deletion of HmsA. Therefore, the regulatory effects of HmsA on the hmsH gene appear to operate at the transcriptional level rather than the post-transcriptional level.
Fig. 2
Fig. 2

Regulatory effects of HmsA on hmsH. a Primer extension results. The relative levels of hmsH transcript were determined in the WT and ∆hmsA mutant strains by primer extension assays. The Sanger sequence ladders (lanes G, C, A and T) and the primer extension products of hmsH were analyzed on an 8 M urea-6 % acrylamide sequencing gel. The transcription start sites of hmsH were indicated by arrows, and the minus number under the arrow indicates the nucleotide position upstream of the hmsH start codon. b qRT-PCR results. The relative levels of the hmsH transcript were determined in the WT and ∆hmsA mutant strains by qRT-PCR. c lacZ fusion results. The hmsH::lacZ transcriptional fusion vector was transformed into the WT and ∆hmsA mutant strains. The transcriptional activity of hmsH determined in the bacterial cellular extracts was represented as Miller units of β-galactosidase activity

HmsA affects the regulation of genes for c-di-GMP synthesis and degradation

Y. pestis contains two genes (hmsT and hmsD) encoding diguanylate cyclase enzymes and one gene (hmsP) encoding the phosphodiesterase enzyme, which all play a role in determining the intracellular level of c-di-GMP. To investigate the regulatory role of HmsA on the hmsT and hmsD genes, the expression levels of hmsT and hmsC (the first gene of the hmsCDE operon) were measured as described for hmsH (Figs. 3 and 4). The abundance of both hmsT and hmsC transcripts was reduced in the ΔhmsA strain compared with the WT strain. However, we found no significant differences in transcriptional activity between the WT and ΔhmsA strains, suggesting that both hmsT and hmsD are likely activated by HmsA at the post-transcriptional level. By contrast, deletion of HmsA did not significantly alter the levels of hmsP transcript (Fig. 5) indicating that the abundance of the hmsP transcript is correlated with HmsA.
Fig. 3
Fig. 3

Regulatory effects of HmsA on hmsT. a Primer extension results. The relative levels of hmsH transcript were determined in the WT and ∆hmsA mutant strains by primer extension assays. The Sanger sequence ladders (lanes G, C, A and T) and the primer extension products of hmsH were analyzed on an 8 M urea-6 % acrylamide sequencing gel. The transcription start sites of hmsH were indicated by arrows, and the minus number under the arrow indicates the nucleotide position upstream of the hmsH start codon. b qRT-PCR results. The relative levels of the hmsH transcript were determined in the WT and ∆hmsA mutant strains by qRT-PCR. c lacZ fusion results. The hmsH::lacZ transcriptional fusion vector was transformed into the WT and ∆hmsA mutant strains. The transcriptional activity of hmsH determined in the bacterial cellular extracts was represented as Miller units of β-galactosidase activity

Fig. 4
Fig. 4

Regulatory effects of HmsA on hmsC. a Primer extension results. The relative levels of hmsH transcript were determined in the WT and ∆hmsA mutant strains by primer extension assays. The Sanger sequence ladders (lanes G, C, A and T) and the primer extension products of hmsH were analyzed on an 8 M urea-6 % acrylamide sequencing gel. The transcription start sites of hmsH were indicated by arrows, and the minus number under the arrow indicates the nucleotide position upstream of the hmsH start codon. b qRT-PCR results. The relative levels of the hmsH transcript were determined in the WT and ∆hmsA mutant strains by qRT-PCR. c lacZ fusion results. The hmsH::lacZ transcriptional fusion vector was transformed into the WT and ∆hmsA mutant strains. The transcriptional activity of hmsH determined in the bacterial cellular extracts was represented as Miller units of β-galactosidase activity

Fig. 5
Fig. 5

Regulatory effects of HmsA on hmsP. a Primer extension results. The relative levels of hmsH transcript were determined in the WT and ∆hmsA mutant strains by primer extension assays. The Sanger sequence ladders (lanes G, C, A and T) and the primer extension products of hmsH were analyzed on an 8 M urea-6 % acrylamide sequencing gel. The transcription start sites of hmsH were indicated by arrows, and the minus number under the arrow indicates the nucleotide position upstream of the hmsH start codon. b qRT-PCR results. The relative levels of the hmsH transcript were determined in the WT and ∆hmsA mutant strains by qRT-PCR. c lacZ fusion results. The hmsH::lacZ transcriptional fusion vector was transformed into the WT and ∆hmsA mutant strains. The transcriptional activity of hmsH determined in the bacterial cellular extracts was represented as Miller units of β-galactosidase activity

HmsA affects the regulation of the biofilm-associated sRNA HmsB

The sRNA HmsB has been recently identified as a biofilm activator by increasing EPS production in Y. pestis [35]. Using the same RNA extracted for the primer extension assay, the mRNA abundance of HmsB and HmsA was investigated by northern blot analysis in the WT and ΔhmsA or ΔhmsB mutant strains (Fig. 6a and b). Surprisingly, the level of HmsB transcript sharply decreased in the absence of hmsA. However, the level of HmsA transcript remained unchanged in the WT and ΔhmsB strains. These data suggested that the transcription of HmsB might be HmsA-dependent but that HmsA transcription is not influenced by HmsB. To further clarify whether HmsA alters the stability of HmsB, the half-life of the HmsB transcript was measured in the WT and ΔhmsA mutant strains by northern blot analysis (Fig. 6c). HmsB was relatively stable for 30 min in the WT strain, but was rapidly degraded in the ΔhmsA mutant, suggesting that HmsA might affect the stability of HmsB in Y. pestis.
Fig. 6
Fig. 6

Regulatory effects of HmsA on HmsB. a Primer extension results. b Confirmation of HmsA and HmsB by northern blot analysis. The transcript of hmsB/hmsA in the WT and ∆hmsA/∆hmsB mutant strains was monitored by northern blotting (upper and bottom panel). c Measurement of the half-life of HmsB. The WT and ∆hmsA strains were grown to exponential phase at 26 °C and then treated with 250 μg/mL of rifampicin. Culture samples were collected at 0, 2, 4, 8, 16 and 32 min and were subject to RNA extraction and northern blotting using 5S rRNA and HmsB probes

Regulatory effects of HmsA on biofilm-related regulators (RovA and RovM) and the ferric uptake regulator (Fur)

RovM has been defined as a virulence regulator and represses the activity of the RovA regulator, which is also able to regulate biofilm formation in Y. pseudotuberculosis and Y. pestis [43–45]. RovA has been shown to repress biofilm formation by negatively regulating hmsT in Y. pestis [21]. The ferric uptake regulator (Fur) is a global regulator of iron homeostasis that contributes to biofilm formation in bacteria [46]. In this study, we monitored changes in the abundance and transcriptional activity of rovA, rovM and fur transcripts in the WT and ΔhmsA mutant strains. Our results showed that the mRNA level of rovA in the ∆hmsA mutant strain was significantly increased compared with that of the WT strain (Fig. 7). By contrast, the mRNA level of rovM in the ∆hmsA strain was significantly decreased, as shown by both northern blotting and qRT-PCR. We also observed the reduced transcriptional activity of rovM in the ∆hmsA strain relative to the WT strain (Fig. 8). This suggested that HmsA carries out transcriptional regulation of rovA and rovM via different mechanisms. No change in the abundance of the fur transcript was detected in the WT and ΔhmsA strains (Fig. 9). Taken together, these data are all consistent with a HmsA-mediated biofilm phenotype.
Fig. 7
Fig. 7

Regulatory effects of HmsA on rovA. a Primer extension results. The relative levels of hmsH transcript were determined in the WT and ∆hmsA mutant strains by primer extension assays. The Sanger sequence ladders (lanes G, C, A and T) and the primer extension products of hmsH were analyzed on an 8 M urea-6 % acrylamide sequencing gel. The transcription start sites of hmsH were indicated by arrows, and the minus number under the arrow indicates the nucleotide position upstream of the hmsH start codon. b qRT-PCR results. The relative levels of the hmsH transcript were determined in the WT and ∆hmsA mutant strains by qRT-PCR. c lacZ fusion results. The hmsH::lacZ transcriptional fusion vector was transformed into the WT and ∆hmsA mutant strains. The transcriptional activity of hmsH determined in the bacterial cellular extracts was represented as Miller units of β-galactosidase activity

Fig. 8
Fig. 8

Regulatory effects of HmsA on rovM. a Primer extension results. The relative levels of hmsH transcript were determined in the WT and ∆hmsA mutant strains by primer extension assays. The Sanger sequence ladders (lanes G, C, A and T) and the primer extension products of hmsH were analyzed on an 8 M urea-6 % acrylamide sequencing gel. The transcription start sites of hmsH were indicated by arrows, and the minus number under the arrow indicates the nucleotide position upstream of the hmsH start codon. b qRT-PCR results. The relative levels of the hmsH transcript were determined in the WT and ∆hmsA mutant strains by qRT-PCR. c lacZ fusion results. The hmsH::lacZ transcriptional fusion vector was transformed into the WT and ∆hmsA mutant strains. The transcriptional activity of hmsH determined in the bacterial cellular extracts was represented as Miller units of β-galactosidase activity

Fig. 9
Fig. 9

Regulatory effects of HmsA on fur. a Primer extension results. The relative levels of hmsH transcript were determined in the WT and ∆hmsA mutant strains by primer extension assays. The Sanger sequence ladders (lanes G, C, A and T) and the primer extension products of hmsH were analyzed on an 8 M urea-6 % acrylamide sequencing gel. The transcription start sites of hmsH were indicated by arrows, and the minus number under the arrow indicates the nucleotide position upstream of the hmsH start codon. b qRT-PCR results. The relative levels of the hmsH transcript were determined in the WT and ∆hmsA mutant strains by qRT-PCR. c lacZ fusion results. The hmsH::lacZ transcriptional fusion vector was transformed into the WT and ∆hmsA mutant strains. The transcriptional activity of hmsH determined in the bacterial cellular extracts was represented as Miller units of β-galactosidase activity

Discussion

Y. pestis evolved from Y. pseudotuberculosis by acquiring novel pathogenic traits, which conferred the ability to cause fatal disease in mammals, and the capacity to form a biofilm in fleas [8, 41, 47]. Two laterally acquired plasmids, pPCP1 and pMT1, have been shown to be essential for Y. pestis pathogenesis and flea transmission, respectively [6–8]. Here we present evidence that plasmid pPCP1 contributes to biofilm formation in Y. pestis. Our study showed that HmsA was implicated in chromosome-encoded regulatory networks of biofilm formation by modulating the concentration of c-di-GMP and EPS production. Until now, two regulatory sRNAs were reported to affect biofilm formation in Y. pestis, which constituted a new class of regulators of biofilm matrix production. Strikingly, the stability of HmsB appeared to be impaired by HmsA. A consecutive 13-nt base pairing region was found at the 5ʹ-terminal region of HmsA and within HmsB using the IntaRNA program (Additional file 2: Figure S2a). Whether the potentially direct interaction between HmsA and HmsB accounts for blocking of the accessibility to ribonuclease remains to be experimentally determined.

Trans-acting sRNAs represent a major class of sRNAs in bacteria. The RNA-binding protein Hfq usually aids the sRNA-mRNA interaction and the stability of sRNAs [48, 49]. HmsA was confirmed as a Hfq-dependent sRNA in our previous study [28]. This promoted us to hypothesize that HmsA would function by interacting with target mRNAs at the post-transcriptional level. To clarify the genetic mechanism by which HmsA promotes biofilm formation, dozens of biofilm-associated genes were chosen for further analysis of HmsA-mediated regulation. We investigated the potential regulatory role of HmsA on related genes at the transcriptional and post-transcriptional level. Our results showed that the loss of hmsA leads to changes in mRNA abundance of a novel sRNA (HmsB), several canonical biofilm-enhancing factor genes (hmsHFRS, hmsT and hmsCDE) and transcriptional regulator genes (rovM and rovA). Subsequently we showed that biofilm phenotype mediated by HmsA is likely due to the transcriptional regulation of HmsB, HmsHFRS, RovA and RovM and post-transcriptional activation of HmsT and HmsD. In this study we focused on the mechanism by which HmsA influenced biofilm formation in Y. pestis, and the regulatory networks are summarized in Fig. 10.
Fig. 10
Fig. 10

Regulatory networks of HmsA on biofilm formation

Notably, most of the tested genes were transcriptionally regulated, suggesting the indirect role of HmsA. Only hmsT and hmsCDE appeared to be post-transcriptionally regulated. In general, sRNAs promote translational activation by either increasing accessibility of the ribosomal binding site on mRNA or adjusting mRNA susceptibility to ribonucleolytic degradation [50]. We predicted the secondary structure of the 5' UTR of HmsT/HmsC and potential interactions between HmsA and HmsT/HmsC using the Mfold (http://mfold.rit.albany.edu) algorithm and the IntaRNA program (http://rna.informatik.uni-freiburg.de/IntaRNA), respectively. The stem-loop structure was found to be located close to the ribosomal binding site or translational start site of both HmsT and HmsC (Additional file 2: Figure S2b and S2c). Interestingly, the interactive sites between HmsA and HmsT/HmsC partially overlap with the stem-loop-forming sites of HmsT/HmsC, which is consistent with the traditional view of sRNA-mediated target activation. However, the precise mechanism by which the hmsT and hmsD transcripts, as well as other mRNAs, are directly targeted by HmsA remains to be further investigated.

Conclusion

In this study the plasmid pPCP1-deriving sRNA HmsA was characterized as an activator of biofilm formation in Y. pestis. The biofilm-associated genes were found regulated by HmsA, implying that sRNAs encoded on the laterally acquired plasmids might involve in the chromosome-based regulatory networks. It provides a further insight into importance of sRNAs in Y. pestis-specific physiology and evolution.

Declarations

Acknowledgements

This study was funded by the National Basic Research Program of China (2014CB744405), the National Natural Science Foundation of China (31430006) and the State Key of Pathogen and Biosecurity (Academy of Military Medical Science, SKLPBS1418).

Availability of data and materials

All data generated or analysized during this study are included in this published article and its supplementary information files.

Authors’ contributions

YH, RY and DZ conceived the study and designed the experiments. ZL performed all the experiments. XG and HW contributed to RNA extraction and northern blotting assay. HF and LL participated in primer extension assay and qRT-PCR. YY and RC performed computational analysis and figure construction. The manuscript was written by YH and ZL, and was revised by RY. All the authors read and approved the final manuscript, The authors declare that they have no competing interests.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, No. 20, Dongdajie, Fengtai, Beijing, 100071, China
(2)
State Key Lab of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center, Beijing, 100094, China
(3)
Anhui Medical University, Hefei, Anhui, 230032, China
(4)
College of Life Sciences, Anhui University, Hefei, Anhui, 230601, China
(5)
The General Hospital of PLA, Beijing, 100853, China

References

  1. Rasmussen S, Allentoft ME, Nielsen K, Orlando L, Sikora M, Sjogren KG, Pedersen AG, Schubert M, Van Dam A, Kapel CM, et al. Early divergent strains of Yersinia pestis in Eurasia 5,000 years ago. Cell. 2015;163(3):571–82.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Erickson DL, Jarrett CO, Wren BW, Hinnebusch BJ. Serotype differences and lack of biofilm formation characterize Yersinia pseudotuberculosis infection of the Xenopsylla cheopis flea vector of Yersinia pestis. J Bacteriol. 2006;188(3):1113–9.View ArticlePubMedPubMed CentralGoogle Scholar
  3. Zhou D, Yang R. Formation and regulation of Yersinia biofilms. Protein Cell. 2011;2(3):173–9.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Perry RD, Fetherston JD. Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev. 1997;10(1):35–66.PubMedPubMed CentralGoogle Scholar
  5. Ramos JL, Gallegos MT, Marques S, Ramos-Gonzalez MI, Espinosa-Urgel M, Segura A. Responses of Gram-negative bacteria to certain environmental stressors. Curr Opin Microbiol. 2001;4(2):166–71.View ArticlePubMedGoogle Scholar
  6. Ferber DM, Brubaker RR. Plasmids in Yersinia pestis. Infect Immun. 1981;31(2):839–41.PubMedPubMed CentralGoogle Scholar
  7. Bearden SW, Fetherston JD, Perry RD. Genetic organization of the yersiniabactin biosynthetic region and construction of avirulent mutants in Yersinia pestis. Infect Immun. 1997;65(5):1659–68.PubMedPubMed CentralGoogle Scholar
  8. Sulakvelidze A. Yersiniae other than Y. enterocolitica, Y. pseudotuberculosis, and Y. pestis: the ignored species. Microbes Infect. 2000;2(5):497–513.View ArticlePubMedGoogle Scholar
  9. Rajanna C, Revazishvili T, Rashid MH, Chubinidze S, Bakanidze L, Tsanava S, Imnadze P, Bishop-Lilly KA, Sozhamannan S, Gibbons HS, et al. Characterization of pPCP1 Plasmids in Yersinia pestis Strains Isolated from the Former Soviet Union. Int J Microbiol. 2010;2010:760819.View ArticlePubMedPubMed CentralGoogle Scholar
  10. Hinnebusch BJ, Erickson DL. Yersinia pestis biofilm in the flea vector and its role in the transmission of plague. Curr Top Microbiol Immunol. 2008;322:229–48.PubMedPubMed CentralGoogle Scholar
  11. Darby C. Uniquely insidious: Yersinia pestis biofilms. Trends Microbiol. 2008;16(4):158–64.View ArticlePubMedGoogle Scholar
  12. Bobrov AG, Kirillina O, Forman S, Mack D, Perry RD. Insights into Yersinia pestis biofilm development: topology and co-interaction of Hms inner membrane proteins involved in exopolysaccharide production. Environ Microbiol. 2008;10(6):1419–32.View ArticlePubMedGoogle Scholar
  13. Abu Khweek A, Fetherston JD, Perry RD. Analysis of HmsH and its role in plague biofilm formation. Microbiology. 2010;156(Pt 5):1424–38.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Romling U, Amikam D. Cyclic di-GMP as a second messenger. Curr Opin Microbiol. 2006;9(2):218–28.View ArticlePubMedGoogle Scholar
  15. Bobrov AG, Kirillina O, Perry RD. The phosphodiesterase activity of the HmsP EAL domain is required for negative regulation of biofilm formation in Yersinia pestis. FEMS Microbiol Lett. 2005;247(2):123–30.View ArticlePubMedGoogle Scholar
  16. Bobrov AG, Kirillina O, Ryjenkov DA, Waters CM, Price PA, Fetherston JD, Mack D, Goldman WE, Gomelsky M, Perry RD. Systematic analysis of cyclic di-GMP signalling enzymes and their role in biofilm formation and virulence in Yersinia pestis. Mol Microbiol. 2011;79(2):533–51.View ArticlePubMedGoogle Scholar
  17. Sun YC, Koumoutsi A, Jarrett C, Lawrence K, Gherardini FC, Darby C, Hinnebusch BJ. Differential control of Yersinia pestis biofilm formation in vitro and in the flea vector by two c-di-GMP diguanylate cyclases. PLoS One. 2011;6(4):e19267.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Sun F, Gao H, Zhang Y, Wang L, Fang N, Tan Y, Guo Z, Xia P, Zhou D, Yang R. Fur is a repressor of biofilm formation in Yersinia pestis. PLoS One. 2012;7(12):e52392.View ArticlePubMedPubMed CentralGoogle Scholar
  19. Sun YC, Hinnebusch BJ, Darby C. Experimental evidence for negative selection in the evolution of a Yersinia pestis pseudogene. Proc Natl Acad Sci U S A. 2008;105(23):8097–101.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Vadyvaloo V, Hinz AK. A LysR-type transcriptional regulator, RovM, senses nutritional cues suggesting that it is involved in metabolic adaptation of Yersinia pestis to the flea gut. PLoS One. 2015;10(9):e0137508.View ArticlePubMedPubMed CentralGoogle Scholar
  21. Liu L, Fang H, Yang H, Zhang Y, Han Y, Zhou D, Yang R. Reciprocal regulation of Yersinia pestis biofilm formation and virulence by RovM and RovA. Open Biol. 2016;6:150198. http://dx.doi.org/10.1098/rsob.150198.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Tam C, Demke O, Hermanas T, Mitchell A, Hendrickx AP, Schneewind O. YfbA, a Yersinia pestis regulator required for colonization and biofilm formation in the gut of cat fleas. J Bacteriol. 2014;196(6):1165–73.View ArticlePubMedPubMed CentralGoogle Scholar
  23. Willias SP, Chauhan S, Lo CC, Chain PS, Motin VL. CRP-mediated carbon catabolite regulation of Yersinia pestis biofilm formation is enhanced by the carbon storage regulator protein, CsrA. PLoS One. 2015;10(8):e0135481.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Rebeil R, Jarrett CO, Driver JD, Ernst RK, Oyston PC, Hinnebusch BJ. Induction of the Yersinia pestis PhoP-PhoQ regulatory system in the flea and its role in producing a transmissible infection. J Bacteriol. 2013;195(9):1920–30.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Chambers JR, Sauer K. Small RNAs and their role in biofilm formation. Trends Microbiol. 2013;21(1):39–49.View ArticlePubMedGoogle Scholar
  26. Waters LS, Storz G. Regulatory RNAs in bacteria. Cell. 2009;136(4):615–28.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Storz G, Vogel J, Wassarman KM. Regulation by small RNAs in bacteria: expanding frontiers. Mol Cell. 2011;43(6):880–91.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Yan Y, Su S, Meng X, Ji X, Qu Y, Liu Z, Wang X, Cui Y, Deng Z, Zhou D, et al. Determination of sRNA expressions by RNA-seq in Yersinia pestis grown in vitro and during infection. PLoS One. 2013;8(9):e74495.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Qu Y, Bi L, Ji X, Deng Z, Zhang H, Yan Y, Wang M, Li A, Huang X, Yang R, et al. Identification by cDNA cloning of abundant sRNAs in a human-avirulent Yersinia pestis strain grown under five different growth conditions. Future Microbiol. 2012;7(4):535–47.View ArticlePubMedGoogle Scholar
  30. Koo JT, Alleyne TM, Schiano CA, Jafari N, Lathem WW. Global discovery of small RNAs in Yersinia pseudotuberculosis identifies Yersinia-specific small, noncoding RNAs required for virulence. Proc Natl Acad Sci U S A. 2011;108(37):E709–17.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Beauregard A, Smith EA, Petrone BL, Singh N, Karch C, McDonough KA, Wade JT. Identification and characterization of small RNAs in Yersinia pestis. RNA Biol. 2013;10(3):397–405.View ArticlePubMedPubMed CentralGoogle Scholar
  32. Schiano CA, Koo JT, Schipma MJ, Caulfield AJ, Jafari N, Lathem WW. Genome-wide analysis of small RNAs expressed by Yersinia pestis identifies a regulator of the Yop-Ysc type III secretion system. J Bacteriol. 2014;196(9):1659–70.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Lathem WW, Schroeder JA, Bellows LE, Ritzert JT, Koo JT, Price PA, Caulfield AJ, Goldman WE. Posttranscriptional regulation of the Yersinia pestis cyclic AMP receptor protein Crp and impact on virulence. mBio. 2014;5(1):e01038–01013.View ArticlePubMedPubMed CentralGoogle Scholar
  34. Schiano CA, Lathem WW. Post-transcriptional regulation of gene expression in Yersinia species. Front Cell Infect Microbiol. 2012;2:129.View ArticlePubMedPubMed CentralGoogle Scholar
  35. Fang N, Qu S, Yang H, Fang H, Liu L, Zhang Y, Wang L, Han Y, Zhou D, Yang R. HmsB enhances biofilm formation in Yersinia pestis. Front Microbiol. 2014;5:685.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Zhou D, Tong Z, Song Y, Han Y, Pei D, Pang X, Zhai J, Li M, Cui B, Qi Z, et al. Genetics of metabolic variations between Yersinia pestis biovars and the proposal of a new biovar, microtus. J Bacteriol. 2004;186(15):5147–52.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A. 2000;97(12):6640–5.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Ni B, Du Z, Guo Z, Zhang Y, Yang R. Curing of four different plasmids in Yersinia pestis using plasmid incompatibility. Lett Appl Microbiol. 2008;47(4):235–40.View ArticlePubMedGoogle Scholar
  39. Liu Z, Wang H, Wang H, Wang J, Bi Y, Wang X, Yang R, Han Y. Intrinsic plasmids influence MicF-mediated translational repression of ompF in Yersinia pestis. Front Microbiol. 2015;6:862.PubMedPubMed CentralGoogle Scholar
  40. Beckmann BM, Grunweller A, Weber MH, Hartmann RK. Northern blot detection of endogenous small RNAs (approximately14 nt) in bacterial total RNA extracts. Nucleic Acids Res. 2010;38(14):e147.View ArticlePubMedPubMed CentralGoogle Scholar
  41. Gao H, Zhou D, Li Y, Guo Z, Han Y, Song Y, Zhai J, Du Z, Wang X, Lu J, et al. The iron-responsive Fur regulon in Yersinia pestis. J Bacteriol. 2008;190(8):3063–75.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Lodge J, Fear J, Busby S, Gunasekaran P, Kamini NR. Broad host range plasmids carrying the Escherichia coli lactose and galactose operons. FEMS Microbiol Lett. 1992;74(2-3):271–6.View ArticlePubMedGoogle Scholar
  43. Heroven AK, Dersch P. RovM, a novel LysR-type regulator of the virulence activator gene rovA, controls cell invasion, virulence and motility of Yersinia pseudotuberculosis. Mol Microbiol. 2006;62(5):1469–83.View ArticlePubMedGoogle Scholar
  44. Heroven AK, Bohme K, Tran-Winkler H, Dersch P. Regulatory elements implicated in the environmental control of invasin expression in enteropathogenic Yersinia. Adv Exp Med Biol. 2007;603:156–66.View ArticlePubMedGoogle Scholar
  45. Cathelyn JS, Crosby SD, Lathem WW, Goldman WE, Miller VL. RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague. Proc Natl Acad Sci U S A. 2006;103(36):13514–9.View ArticlePubMedPubMed CentralGoogle Scholar
  46. Benjamin JA, Desnoyers G, Morissette A, Salvail H, Masse E. Dealing with oxidative stress and iron starvation in microorganisms: an overview. Can J Physiol Pharmacol. 2010;88(3):264–72.View ArticlePubMedGoogle Scholar
  47. Wassarman KM. Small RNAs in bacteria: diverse regulators of gene expression in response to environmental changes. Cell. 2002;109(2):141–4.View ArticlePubMedGoogle Scholar
  48. Desnoyers G, Bouchard MP, Masse E. New insights into small RNA-dependent translational regulation in prokaryotes. Trends Genet. 2013;29(2):92–8.View ArticlePubMedGoogle Scholar
  49. Vogel J, Luisi BF. Hfq and its constellation of RNA. Nat Rev Microbiol. 2011;9(8):578–89.View ArticlePubMedPubMed CentralGoogle Scholar
  50. Papenfort K, Vanderpool CK. Target activation by regulatory RNAs in bacteria. FEMS Microbiol Rev. 2015;39(3):362–78.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement

BMC Microbiology

ISSN: 1471-2180

Contact us